Stemline Therapeutics Announces ELZONRIS Clinical Data Selected for Presentation at the Upcoming ASCO Annual Meeting

NEXT STORY
Kiniksa to Present Data on the Burden of Disease in Patients with Recurrent Pericarditis at the International Society for Pharmacoeconomics and Outcomes Research
PREV STORY
Geron Continues to Build Senior Leadership of Its Development Team
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cybin Corp. CEO Discusses Ongoing Efforts to Develop One of the First Commercially Approved Psychedelic Medications for Mental Health

author_avatar
NASDAQ Market News

Tempus and Sanford Health Collaborate on Personalized Medicine Initiative

CHICAGO, Nov. 01, 2017 (GLOBE NEWSWIRE) -- Tempus, a rapidly-growing technology company focused on ...

author_avatar
NASDAQ Market News

Biogen Advances Leading Research in Spinal Muscular Atrophy (SMA) with New Data at AAN 2021 Exploring Opportunities to Improve Outcomes for Patients

author_avatar
NASDAQ Market News